Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radient Pharmaceuticals
Tustin, California, United States
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
The Onko-Sure IVD Cancer Test Kit was FDA-approved for colorectal cancer monitoring, Health Canada-approved for lung cancer, and CE marked for general cancer screening. Commercial launch in 2009 resulted in modest sales (1005 kits; $266,000 revenue, below forecast)
- Therapeutic areas
- Oncology
- Modalities
- In vitro diagnostic (IVD) testsimmunoassays
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
No major pharma/biotech partnerships reported; international regulatory and distribution partnerships for test kit
Beyond the preview
Go deeper on Radient Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Radient Pharmaceuticals.